A comparison of the effects of oral vs. intravenous hydration on subclinical acute kidney injury in living kidney donors: a protocol of a randomised controlled trial

BMC Nephrol. 2017 Jan 19;18(1):30 doi: 10.1186/s12882-017-0447-3.
Abstract
BACKGROUND:

Optimal treatment for established renal failure is living donor kidney transplantation. However this pathway exposes healthy individuals to significant reduction in nephron mass via major surgical procedure. Laparoscopic donor nephrectomy is now the most common method for live donor transplantation, reducing both donor post-operative pain and recovery time. However this procedure exposes kidneys to additional haemodynamic stresses. It has been suggested that donor hydration-particularly the use of preoperative intravenous fluids-may counteract these stresses, reducing subclinical acute kidney injury and ultimately improving long-term renal function. This may be important in both preservation of donor renal function and recipient graft longevity.

METHODS/DESIGN:

A prospective single-centre single-blinded randomized controlled trial will be carried out to determine the effects of donor preoperative intravenous fluids. The primary outcome is donor subclinical acute kidney injury (defined as plasma NGAL, >153 ng/ml) on day 1 postoperatively. Secondary outcomes include intraoperative haemodynamics, recipient subclinical acute kidney injury, perioperative complications and donor sleep quality. Donors will be randomised into two groups: the intervention group will receive active pre-hydration consisting of three litres of intravenous Hartmann's solution between midnight and 8 am before morning kidney donation, while the control group will not receive this. Both groups will receive unlimited oral fluids until midnight, as is routine. Plasma NGAL will be measured at pre-specified perioperative time points, intraoperative haemodynamic data will be collected using non-invasive cardiac output monitoring and clinical notes will be used to obtain demographic and clinical data. The researcher will be blinded to the donor fluid hydration status. Blinded statistical analysis will be performed on an intention-to-treat basis. A prospective power calculation estimates a required sample size of 86 patients.

DISCUSSION:

This study will provide important data, as there is currently little evidence about the use of donor preoperative fluids in laparoscopic nephrectomy. It is hoped that the results obtained will guide future clinical practice.

TRIAL REGISTRATION:

This study has been approved by the West of Scotland Research Ethics Committee 3 (reference no. 14/WS/1160, 27 January 2015) and is registered with the International Standard Randomised Controlled Trial Number Register (reference no. ISRCTN10199225 , 20 April 2015).

CET Conclusion
Reviewer: Dr Liset Pengel, Centre for Evidence in Transplantation, The Royal College of Surgeons of England.
Conclusion: This is a trial protocol of a single centre, single-blinded randomised controlled trial comparing the effect of intravenous hydration on subclinical acute kidney injury in living kidney donors. Living kidney donors will be randomised to 3 litres of intravenous Hartmann’s solution between midnight and 8am before morning donation with unlimited oral fluids versus unlimited oral fluids until midnight alone. The randomisation sequence will be computer-generated and allocation will be concealed by using sealed, opaque envelopes. The primary outcome is the incidence of plasma NGAL>153ng/ml on day 1 posttransplant as a biomarker for donor acute kidney injury. Secondary outcomes include donor and recipient biochemical and clinical outcomes. The power calculation showed that 43 donors per group are needed to detect a 30% difference in the incidence rate of acute kidney injury, allowing for 10% dropout/withdrawal. Outcome assessment and data entry will be done in a blinded fashion.
Study Details
Aims: To determine the effects of donor preoperative intravenous fluids compared to oral hydration in living kidney donors.
Interventions: Participants will be randomised to receive either active prehydration with three litres of intravenous Hartmann’s solution between midnight and 8am with unlimited oral fluid as desired, versus unlimited oral fluids only until midnight.
Participants: Adult patients aged >18 years of age undergoing live donor hand-assisted laparoscopic nephrectomy.
Outcomes: The primary outcome measured will be the incidence of donor acute kidney injury on day 1 post-operatively. Secondary outcomes will include intraoperative haemodynamics, recipient subclinical acute kidney injury, perioperative complications and donor sleep quality.
Follow Up: 1 year
Metadata
Publication type: Randomized Controlled Trial, Randomised Controlled Trial
Organ: Kidney
Language: English
MeSH terms: Acute Kidney Injury; Administration, Oral; Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Dose-Response Relationship, Drug; Female; Fluid Therapy; Graft Survival; Humans; Injections, Intravenous; Kidney Transplantation; Living Donors; Male; Middle Aged; Premedication; Rehydration Solutions; Treatment Outcome; Young Adult; Aged, 80 and Over; 0 (Rehydration Solutions)